Publication | Open Access

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

Histone ModificationsChromatinCancer TherapyOncologyRecent Clinical TrialsChromatin RemodelingMedicineAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer Research